Clinical Trial

The Use of the Dexcom G6® in Commercial Pilots With Insulin-treated Diabetes

Study acronym: DEXFLY2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To compare glucose control achieved by using real time continuous glucose monitoring (CGMS) Dexcom G6® in combination with self-monitored blood glucose during flight and also with free living in pilots.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-01-08; most recent amendment 2025-11-18.
Status change: Recruiting → Active, Not Recruiting 2024-12-12
Trial Details
NCT Number NCT04225455
Lead Sponsor University of Surrey
Collaborators: DexCom, Inc.
Conditions Insulin Dependent Diabetes
Enrollment 17 participants
Start Date 2019-12-05
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-24